Animal Antibiotics and Antimicrobials Market Size, Share, Growth, and Industry Analysis, By Type (Tetracyclines, Penicillin, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lacosamide & Cephalosporins), By Application (Food-producing Animals & Companion Animals) and Regional Insights and Forecast to 2034

•   
•   
  

  Download Free Sample to learn more about this report

    

ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET REPORT OVERVIEW

The global Animal Antibiotics and Antimicrobials Market size is estimated to be USD 4.2411 billion in 2025, and the market is projected to touch USD 5.4891 billion by 2034, exhibiting a CAGR of approximately 2.9% during the 2025–2034 forecast period.

The use of animal antimicrobials and antibiotics is very significant in veterinary medicine because it also fulfils the crucial role of treating, controlling and preventing microorganism-induced infectious diseases in companion and food-producing animals like poultry, cattle and swine. These products are classes, e.g., tetracyclines, penicillin and macrolides, taken with various modes like injecting, oral powder or feed premixes to help in safeguarding the welfare and health of the animals and hence, the health of the people through the preservation of a healthy food supply.

COVID-19 IMPACT

Market Growth Accelerated by Pandemic due to Concept of One Health

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market growth and demand returning to pre-pandemic levels.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 25%.

The greatest positive impact of the COVID-19 pandemic on this Market was the rising emphasis on the concept of One Health, which emphasizes the interdependence of human and animal health, thereby making the world more conscious of the problem of the zoonotic diseases and antimicrobial resistance (AMR). This increased consciousness in combination with a rise in the number of companion animals adopted and a long-term, high demand in animal-based foodstuffs prompted a growth in the expenditure on animal health products and biosecurity, which ultimately encouraged future growth in the market and investment in the veterinary pharmaceutical market.

LATEST TRENDS

Antimicrobial Stewardship to Propel Market Growth

This market is currently characterized by a resurgence of interest in antimicrobial stewardship and the search for alternatives, largely in reaction to increasing concerns and strict regulations in the world on the issue of antimicrobial resistance (AMR). One of the main trends is the movement toward animal-only antibiotics and the creation of long-acting injectable preparations to enhance principles of compliance during treatment and to decrease the frequency of handling, particularly in animal production.

•   
•   
  

  Download Free Sample to learn more about this report

    

ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Tetracyclines, Penicillin, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lacosamide & Cephalosporins

• Tetracyclines: These drugs are well-known because of the broad spectrum of action and ability to treat a variety of bacterial infections in animals and in food-producing animals (livestock and poultry).

• Penicillin: Penicillin constitutes another major market sector in terms of selling veterinary antibiotics. Different forms of this class exist, such as narrow-spectrum (e.g., ampicillin and amoxicillin) and broad-spectrum (e.g., ampenicillin), which is frequently administered together with the use of the beta-lactamase inhibitor to maximize the effect.

• Macrolides: Take a significant market share. The macrolides are significant, especially in the management of respiratory infections in livestock (including Bovine Respiratory Disease – BRD) and dermatology in pet species.

• Aminoglycosides: This is another category of drugs, such as amikacin, apramycin and gentamicin, which belong to the veterinary antibiotics market. They are mostly applied to severe gram-negative infections.

• Sulfonamides: commonly used together with other medications such as trimethoprim (e.g., sulfadiazine, sulfamethoxazole), fall within the market segmentation. They are useful in veterinary medicine, as they are effective against a variety of bacterial pathogens.

• Fluoroquinolones: frequently estimated as increasing at the leading Compound Annual Growth Rate (CAGR) of the drug category. They are powerful and have a broad spectrum of coverage, and their application is facing growing criticism and control because of their significance in human medicine and fears of antimicrobial resistance (AMR).

• Lacosamide: A group that is utilized in the market, like lincomycin and clindamycin. They are mainly useful in anaerobic bacteria and a gram-positive coccus.

• Cephalosporins: Cephalosporins (including many generations, such as cefalexin and ceftiofur) represent another category of the veterinary antibiotics industry. They provide a broad range of activities and are utilized in several indications to animals.

By Application

Based on application the market can be categorized into Food-producing Animals & Companion Animals

• Food-Producing Animals: The segment, which comprises cattle, poultry, swine, sheep and goats, always takes the lead in terms of the quantity of antibiotics consumed. This volume is especially large with the contribution of the cattle and poultry segments.

• Companion Animals: which comprises dogs, cats and horses, is generally estimated to have the greatest Compound Annual Growth Rate (CAGR) in the veterinary antibiotics business. To a large extent, this increased growth is due to the pet humanization trend in which the owner treats pets as family members, thus being willing to spend more money on higher levels of veterinary care, such as individual illness treatment with antibiotics.

MARKET DYNAMICS

Driving Factors

Increased International Requirement of Animal Protein and Intensive Agriculture to Drive the Market Advancement

One of the major driving factors of the Animal Antibiotics and Antimicrobials Market Growth because of the Increased International Requirement of Animal Protein and Intensive Agriculture. One of the motivating factors of this market is the growing global consumption of animal protein food items, including meat, milk, and eggs. This is an increasing demand, especially in developing economies where the population and disposable income are on the rise, requiring expansion and intensification of commercial livestock and poultry farming. Bacterial infections and diseases are much more likely to occur and spread at a high rate in these high-density animal production systems (cattle, poultry, swine).

Raising Pet Ownership and Companion Animal Healthcare Spending to Expand the Market

One more influential force, which mainly affects market value and technological development, is the boom in the number of companion animals and the related trend in humanizing their pets, especially in North America and Europe. The owners are becoming ready to pay huge sums of money on quality veterinary services for their pets (dogs, cats, and horses), including advanced diagnostic and treatment services.

Restraining Factor

Antimicrobial Resistance to the Market Growth

The greatest inhibiting force in this market is the increased threat of antimicrobial resistance in the world as well as tighter government laws. The increasing number of national and international regulatory bodies (such as the FDA and EMA) have become more restrictive due to the growing national and international public health concern with the fact that antibiotic resistance, which can be passed on to humans by animals through the food chain or direct contact, is growing.

Animal Protein to the Market Growth

Opportunity

One of the biggest opportunity considerations in this market is the fact that the world is quickly growing its demand to consume animal protein and that there is an increase in the amount of money that is spent on healthcare for the companion animals, which will necessitate the management of the disease.

Exponential increase in livestock production (meat, milk, and eggs) and pet ownership worldwide, and especially among emerging economies, is driven by the growing world population, increase in disposable income, and the changes in dietary habits.

Harsh Regulatory Limitations to Challenge the Market Growth

Challenge

The only major challenge driver to the market of veterinary antibiotics is the threat of Antimicrobial Resistance (AMR) that is growing rapidly, and the harsh regulatory limitations aimed at its reduction.

The large-scale and indiscriminate use of antibiotics in farm animals, especially livestock, develops a selective pressure that results in the selection of resistant bacteria, which can be further spread to people via the food chain or direct contact, and this puts the health of not only the animals at risk but also that of people.

•   
•   
  Download Free Sample to learn more about this report

    

ANIMAL ANTIBIOTICS AND ANTIMICROBIALSR MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

• North America

North America has emerged as the most dominant region in the Animal Antibiotics and Antimicrobials Market share because of the excessive spending on companion animal medical care and developed veterinary facilities. The market is being motivated by rising pet ownership, a high rate of zoonotic and livestock diseases, and a high demand for animal products. The U.S. is a leader in both regulation tendencies and technological advancement at the world level. There is a push towards alternative therapy in the market in terms of vaccines, probiotics and other non-antibiotic therapies that are usually instigated by FDA and USDA regulations that control the common use of antibiotics in food-producing animals. Moreover, the demand for meat without antibiotics is a key issue that affects the market since it affects livestock production and promotes the use of digital diagnostics and precision livestock farming to maximize the use of antibiotics.

• Europe

Europe enjoys the international reputation of its innovative and stringent regulation of veterinary antibiotics. Such regulations as the EU Veterinary Medicines Regulation (Regulation (EU) 2019/6) and the prohibition of antibiotic use as growth promoters (since 2006) saw a significant decrease in total antibiotic sales (more than a 43% decrease in sales since 2011). The European market is driven by such an emphasis on prudent use guidelines, or responsible use, towards disease prevention by vaccines and biosecurity. The Farm to Fork strategy has established a goal to bring down general sales of antimicrobials to all animals by half 2030, and Europe leads the way in establishing the worldwide standard on antimicrobial stewardship.

• Asia

The veterinary antibiotics market in Asia is one of the large growth drivers, as it is driven mainly by the huge and rising amount of demand for animal protein because of the fast population growth, urbanization and rising disposable income, especially in such countries as China and India. The introduction of intensive farming and aquaculture also requires the consumption of antibiotics to keep herds healthy and productive. Although the market has been marked by an increase in the rate of antibiotic use, the market is also witnessing an upward trend in terms of stewardship programmes and stricter government regulations as the appreciation of antimicrobial resistance and zoonotic diseases increases.

KEY INDUSTRY PLAYERS

Key Players Transforming the Animal Antibiotics and Antimicrobials Landscape through Innovation and Global Strategy

The most influential fact of the veterinary antibiotics market is the interaction between the global demand for animal protein and the growing pressure of the population and regulatory bodies in relation to antimicrobial resistance (AMR). This increase in livestock production and keeping of pets defines a minimum requirement of antibiotics to keep animals healthy and productive; the major animal health companies are actively seeking new animal-only antibiotics, new drug delivery systems (such as long-acting injectables) and non-antibiotic alternatives (such as vaccines and diagnostics) to meet the requirements set by the stricter antimicrobial stewardship programmes globally and address the risk of AMR, which ultimately directs the development and adoption of new products in the market.

List Of Market Players Profiled

• Zoetis, Inc. (New Jesrsey)
• Merck & Co., Inc. (New Jersey)
• Eli Lilly and Company (U.S.)
• Bayer AG (Germany)
• Virbac (France)

INDUSTRIAL DEVELOPMENT

February 4, 2025: Elanco Animal Health Incorporated introduced the Pradalex™ (pradofloxacin injection) in the management of bovine respiratory disease (BRD) and swine respiratory disease (SRD). It was identified to be the first new injectable and oral treatment of BRD and SRD approved in the United States by the FDA in approximately 20 years.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis considers both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.